Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Gan To Kagaku Ryoho ; 41(12): 1566-8, 2014 Nov.
Artigo em Japonês | MEDLINE | ID: mdl-25731254

RESUMO

There is insufficient evidence for the pre-operative use of chemoradiotherapy (CRT) in treatment of advanced rectal cancers, and its efficiency and safety are unclear. However, it has recently been suggested that a new class of carcinostatic agents are more effective during preoperative CRT. Under the National Comprehensive Cancer Network (NCCN) guidelines, 5-FU and capecitabine have been recommended as the standard drugs for use during combination chemoradiotherapy. The Japanese Society for Cancer of Colon and Rectum (JSCCR) guidelines for 2014 also recommend the use of both drugs during preoperative CRT. We report a case of rectal cancer, which was successfully treated with radical resection and neoadjuvant chemoradiotherapy.


Assuntos
Adenocarcinoma/terapia , Antimetabólitos Antineoplásicos/uso terapêutico , Quimiorradioterapia , Desoxicitidina/análogos & derivados , Fluoruracila/análogos & derivados , Neoplasias Retais/terapia , Adenocarcinoma/complicações , Idoso de 80 Anos ou mais , Capecitabina , Desoxicitidina/uso terapêutico , Fluoruracila/uso terapêutico , Humanos , Íleus/etiologia , Masculino , Estadiamento de Neoplasias , Neoplasias Retais/complicações , Neoplasias Retais/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA